Does TNF rs1800629 AG increase inflammatory signaling and pressure on zinc homeostasis?

The TNF rs1800629 (-308G>A) polymorphism is a functional promoter variant that acts as a primary genetic driver of systemic inflammation, carrying direct consequences for cellular and systemic zinc regulation.

Genetic mechanisms of elevated inflammation

• The transition from the wild-type G allele to the A allele alters transcription factor binding, specifically recruiting an A-specific nuclear factor and altering Sp1 binding configurations.
• Reporter assays show that the high-activity A allele drives a 1.5- to 3-fold (and up to 8-fold) increase in promoter activity compared to G-containing constructs, leading to elevated baseline and inducible TNF-alpha transcription in heterozygous AG individuals.
• Clinically, this genetic profile correlates with elevated systemic inflammatory markers, including circulating TNF-alpha, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR).

Impact on zinc homeostasis and transporter dynamics

• Heightened inflammatory signaling from elevated TNF-alpha induces "hypozincemia of inflammation," an active process that redistributes zinc from blood plasma into hepatic and other cellular compartments.
• At the molecular level, TNF-alpha-induced activation of NF-kB upregulates the expression of the ZIP8 zinc importer, while other inflammatory cytokines concurrently upregulate ZIP14.
• This coordinated upregulation of ZIP8 and ZIP14 drives rapid cellular zinc influx, where the metal is buffered by intracellular metallothioneins, altering systemic zinc homeostasis and reducing circulating zinc availability.

Bottom line

• The TNF rs1800629 AG genotype increases baseline and inducible TNF-alpha production, which exerts inflammatory pressure on zinc homeostasis by upregulating ZIP8 and ZIP14 transporters and driving zinc from circulation into cellular compartments.